A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...

ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...

In the first State of the Union address of his second term, President Donald Trump played the health care hits, touting ...

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

A global study found COVID-19 booster vaccination during pregnancy was associated with lower odds of preeclampsia, even among ...

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical models of HPV-related cancerEVANSTON, Ill.--(BUSINESS ...

New research shows how poultry vaccination programs successfully combat Salmonella, with surprising insights into infection sources and prevention.

Researchers have reported that a topical gene therapy which can correct disease-causing mutations directly in human skin, raising the prospect of durable treatments for rare genetic skin ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Nipah virus fatality rates are 40% to 75%. It's typically spread between humans and bats through people consuming ...

Among an upended global health order, medical innovation pushes forward. Read how TIME chose the list of doctors, scientists and more.